Satoshi Otsu

机构：Oita University

发表论文 88 篇 · 总被引 531 次 · h-index 14

代表论文

• C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel (2023 · Scientific Reports · 被引 19)
• Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer (2023 · Scientific Reports · 被引 18)
• Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study) (2022 · BMC Cancer · 被引 17)
• A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer (2024 · Scientific Reports · 被引 13)
• Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer (2021 · Pancreas · 被引 12)
• Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel (2023 · Anticancer Research · 被引 11)